Overall Incidence Rate of Pediatric Cancer Increased From 2003 to 2019
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 12, 2023 -- The overall incidence rate of pediatric cancer increased on average from 2003 to 2019, peaking in 2016, according to a study published online July 11 in the Journal of the National Cancer Institute.
David A. Siegel, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues updated cancer incidence rates and trends using data from U.S. Cancer Statistics for children and adolescents aged younger than 20 years diagnosed with malignant tumors during 2003 to 2019.
A total of 248,749 cases were reported during 2003 to 2019, for an overall cancer incidence rate of 178.3 per 1 million. The researchers found that the incidence rates were highest for leukemia, central nervous system (CNS) neoplasms, and lymphoma (46.6, 30.8, and 27.3, respectively). Boys, children aged 0 to 4 years, non-Hispanic White children and adolescents, and those in the Northeast census region, the top 25 percent of counties by economic status, and metropolitan counties with a population of 1 million or more had the highest rates. On average, from 2003 to 2019, the overall incidence rate of pediatric cancer increased 0.5 percent per year, with the rate increasing during 2003 to 2016 and then decreasing during 2016 to 2019 (annual percentage change, 1.1 and −2.1 percent, respectively). Increases were seen in the rates of leukemia, lymphoma, hepatic tumors, bone tumors, and thyroid carcinomas during 2003 to 2019, while the rates of melanoma decreased. The rates of CNS neoplasms increased until 2017, then decreased.
"For some cancer types, further investigation is needed to better understand factors that might affect increases and decreases in trends," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
2024 ASCO Annual Meeting to Focus on Clinical Cancer Research Impacting Patient Care
THURSDAY, May 23, 2024 -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held May 31 to June 4, 2024, in Chicago and online. The theme of this...
Metformin Use Linked to Lower Odds of Myeloproliferative Neoplasms
THURSDAY, May 23, 2024 -- Metformin use, including long-term use, is associated with significantly lower odds of myeloproliferative neoplasm (MPN) diagnosis, according to a study...
Metastatic Cancer Survival No Better at Practices With Higher NQF 0210 Rates
WEDNESDAY, May 22, 2024 -- For patients with metastatic or advanced cancer, treatment at practices with higher rates of National Quality Forum (NQF) 0210 (patients receiving...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.